Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy

Bibliographic Details
Title: Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy
Authors: Ma, Shuo *, Seymour, John F. *, *, Brander, Danielle M., Kipps, Thomas J., Choi, Michael Y., Anderson, Mary Ann, Humphrey, Kathryn, Al Masud, Abdullah, Pesko, John, Nandam, Ruby, Salem, Ahmed Hamed, Chyla, Brenda, Arzt, Jennifer, Jacobson, Amanda, Kim, Su Young, Roberts, Andrew W.
Source: In Blood 9 September 2021 138(10):836-846
Database: ScienceDirect
More Details
ISSN:00064971
DOI:10.1182/blood.2020009578
Published in:Blood
Language:English